相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral PI3 kinase inhibitor BKM120 monotherapy in patients (pts) with advanced solid tumors: An update on safety and efficacy.
B. Grana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification
Melanie G. Cornejo et al.
BLOOD (2011)
PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
Mary E. Urick et al.
CANCER RESEARCH (2011)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
Meghan L. Rudd et al.
CLINICAL CANCER RESEARCH (2011)
Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies
Janet E. Dancey et al.
FUTURE ONCOLOGY (2011)
A phase I study of CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110δ, in combination with anti-CD20 monoclonal antibody therapy and/or bendamustine in patients with previously treated B-cell malignancies.
I. W. Flinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A dose-escalation study with the novel formulation of the oral pan-class I PI3K inhibitor BEZ235, solid dispersion system (SDS) sachet, in patients with advanced solid tumors.
J. D. Peyton et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase I study of CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110d, in patients with previously treated chronic lymphocytic leukemia.
S. E. Coutre et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following clinical benefit from prior standard cytotoxic chemotherapy (CT).
S. P. Chawla et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2-Overexpressing Locally Advanced Breast Cancers
Bhuvanesh Dave et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer
Vienna Ludovini et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Disruption of the AKT Pathway Inhibits Metastasis in an Orthotopic Model of Head and Neck Squamous Cell Carcinoma
Joseph A. Knowles et al.
LARYNGOSCOPE (2011)
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy
Xia Pu et al.
LUNG CANCER (2011)
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
Arantza Farina Sarasqueta et al.
CELLULAR ONCOLOGY (2011)
The Sex-Determining Region Y-Box 4 and Homeobox C6 Transcriptional Networks in Prostate Cancer Progression Crosstalk with the Wnt, Notch, and PI3K Pathways
Carlos S. Moreno
AMERICAN JOURNAL OF PATHOLOGY (2010)
Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
Christoph Lahtz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
Clare G. Fedele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Activity of any class IA PI3K isoform can sustain cell proliferation and survival
Lazaros C. Foukas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Tom D. Bunney et al.
NATURE REVIEWS CANCER (2010)
hVps15, but not Ca2+/CaM, is required for the activity and regulation of hVps34 in mammalian cells
Ying Yan et al.
BIOCHEMICAL JOURNAL (2009)
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
K. Shoji et al.
BRITISH JOURNAL OF CANCER (2009)
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients
Iwona K. Kolasa et al.
CANCER BIOLOGY & THERAPY (2009)
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Christina Gewinner et al.
CANCER CELL (2009)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Martin L. Sos et al.
CANCER RESEARCH (2009)
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
Jing-song Chen et al.
HEPATOLOGY RESEARCH (2009)
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma
Alessandra Capodanno et al.
HUMAN PATHOLOGY (2009)
Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes
Anne Simonsen et al.
JOURNAL OF CELL BIOLOGY (2009)
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor-Positive Breast Cancer
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer
Olga C. J. Schuurbiers et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Oncogenic Ras Signals through Activation of Both Phosphoinositide 3-Kinase and Rac1 to Induce c-Jun NH2-Terminal Kinase-Mediated, Caspase-Independent Cell Death
Joo-Yun Yun et al.
MOLECULAR CANCER RESEARCH (2009)
Essential function for the GTPase TC21 in homeostatic antigen receptor signaling
Pilar Delgado et al.
NATURE IMMUNOLOGY (2009)
Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110γ
Barbara Kurig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of phosphoinositide 3-kinase expression in health and disease
Klaartje Kok et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Vincent Duronio
BIOCHEMICAL JOURNAL (2008)
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
M. S. Kim et al.
BRITISH JOURNAL OF CANCER (2008)
A novel AKT3 mutation in melanoma tumours and cell lines
M. A. Davies et al.
BRITISH JOURNAL OF CANCER (2008)
Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Pieter J. A. Eichhorn et al.
CANCER RESEARCH (2008)
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung
Donatella Malanga et al.
CELL CYCLE (2008)
Phosphoinositide 3-kinases p110α and p110β regulate cell cycle entry, exhibiting distinct activation kinetics in G1 Phase
Miriam Marques et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Mariona Graupera et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ
Julie Guillermet-Guibert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion
Sanjeev Shulkla et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
PIK3CA mutation and amplification in human lung cancer
Koji Okudela et al.
PATHOLOGY INTERNATIONAL (2007)
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling
M. Beeram et al.
ANNALS OF ONCOLOGY (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
John K. Wiencke et al.
NEURO-ONCOLOGY (2007)
Cancer-specific mutations in phosphatidylinositol 3-kinase
Peter K. Vogt et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Binding of Ras to phosphoinositide 3-kinase p110α is required for Ras-driven tumorigenesis in mice
Surbhi Gupta et al.
CELL (2007)
The mammalian target of rapamycin signaling pathway: Twists and turns in the road to cancer therapy
Robert T. Abraham et al.
CLINICAL CANCER RESEARCH (2007)
Unraveling the mechanisms of endocrine resistance in breast cancer: New therapeutic opportunities
Suleiman Massarweh et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer
Joachim Woenckhaus et al.
VIRCHOWS ARCHIV (2007)
Gβγs and the Ras binding domain of p110γ are both important regulators of PI(3)Kγ signalling in neutrophils
Sabine Suire et al.
NATURE CELL BIOLOGY (2006)
Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma
Paul G. Ekert et al.
BLOOD (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Epigenetic silencing of the PTEN gene in melanoma
Alireza Mirmohammadsadegh et al.
CANCER RESEARCH (2006)
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
LC Foukas et al.
NATURE (2006)
Loss of class IAPI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia
Ji Luo et al.
CELL METABOLISM (2006)
Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase γ that is highly expressed in heart and interacts with PDE3B
P Voigt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PIK3CA mutations in breast cancer are associated with poor outcome
SY Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
BCR-ABL regulates phosphatidylinositol 3-kinase-p110γ transcription and activation and is required for proliferation and drug resistance
FB Hickey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
S Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Loss of class I(A)PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia
Ji Luo et al.
CELL (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
Li Ma et al.
CELL (2006)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
The Akt/PKB pathway: molecular target for cancer drug discovery
JQ Cheng et al.
ONCOGENE (2005)
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30H-kinase
T Nobukuni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Turning signals on and off: GLUT4 traffic in the insulin-signaling highway (vol 20, pg 271, 2005)
FSL Thong et al.
PHYSIOLOGY (2005)
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase
MP Byfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway
HW Shin et al.
JOURNAL OF CELL BIOLOGY (2005)
Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors
GJ Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Turning signals on and off: GLUT4 traffic in the insulin-signaling highway
FSL Thong et al.
PHYSIOLOGY (2005)
Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
P Sujobert et al.
BLOOD (2005)
The role of RhoA in the regulation of cell morphology and motility
V Tkach et al.
CELL MOTILITY AND THE CYTOSKELETON (2005)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
L Ma et al.
CELL (2005)
Frequent mutation of the PIK3CA gene in ovarian and breast cancers
DA Levine et al.
CLINICAL CANCER RESEARCH (2005)
Signalling by PI3K isoforms: insights from gene-targeted mice
B Vanhaesebroeck et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
p84, a new Gβγ-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110γ
S Suire et al.
CURRENT BIOLOGY (2005)
Frequent genetic and biochemical alterations of the PI3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma
JMG Pedrero et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
GJ Wu et al.
BREAST CANCER RESEARCH (2005)
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers
A Goel et al.
CANCER RESEARCH (2004)
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
JM García et al.
GENES CHROMOSOMES & CANCER (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT
AM Mirza et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity
LA DeGraffenried et al.
CLINICAL CANCER RESEARCH (2004)
Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis
BD Manning
JOURNAL OF CELL BIOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate
P Rodriguez-Viciana et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1α in non-small cell lung cancers
Y Hirami et al.
CANCER LETTERS (2004)
Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
K Ali et al.
NATURE (2004)
Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils
SJ Gardai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Oncogenic mutations of PIK3CA in human cancers
Y Samuels et al.
CELL CYCLE (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas
M Mizoguchi et al.
BRAIN PATHOLOGY (2004)
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
JB Brugarolas et al.
CANCER CELL (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide
S Babaei et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIk3CA amplification in gastric carcinoma
DS Byun et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras
C Jiménez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
AR Tee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy
LD Mayo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Promoter methylation and silencing of PTEN in gastric carcinoma
YH Kang et al.
LABORATORY INVESTIGATION (2002)
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation
OV Vieira et al.
JOURNAL OF CELL BIOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
H Cho et al.
SCIENCE (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Five isoforms of the phosphatidylinositol 3-kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations
I Inukai et al.
FEBS LETTERS (2001)
Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae
A Kihara et al.
JOURNAL OF CELL BIOLOGY (2001)
A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells
C Bénistant et al.
ONCOGENE (2000)
Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line
RJ DeFatta et al.
LARYNGOSCOPE (2000)
PIK3CA as an oncogene in cervical cancer
YY Ma et al.
ONCOGENE (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
Phosphoinositide signaling and the regulation of membrane trafficking in yeast
G Odorizzi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
BH Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
E Hirsch et al.
SCIENCE (2000)
Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
T Sasaki et al.
SCIENCE (2000)
分享论文
